Back
Kiniksa Pharmaceuticals Vs. Manhattan Associates Industry Stock Comparison
Buy
80
KNSA
Kiniksa Pharmaceuticals
Last Price:
20.08
Seasonality Move:
11.27%
Sell
49
MANH
Manhattan Associates
Last Price:
210.80
Seasonality Move:
6.34%
Buy
80
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals [KNSA] share price is $20.08. The Score for KNSA is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Manhattan Associates (MANH)
is a Sell
Is Manhattan Associates a Buy, Sell or Hold?
- The current Manhattan Associates [MANH] share price is $210.76. The Score for MANH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- MANH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals's stock price today?
-
The Kiniksa Pharmaceuticals share price today is $20.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing slight buying pressure.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $210.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MANH is experiencing slight buying pressure.
KNSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 69.5 | Buy |
Chaikin Money Flow: | 72470 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.14 - 18.88) | Buy |
Bollinger Bands (100): | (17.78 - 20.08) | Buy |
MANH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.55 | Sell |
Relative Strength Index (14 RSI): | 31.82 | Sell |
Chaikin Money Flow: | 48155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (213.33 - 241.89) | Sell |
Bollinger Bands (100): | (215.35 - 250.31) | Sell |
KNSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.69 | Buy |
20-day SMA: | 17.89 | Buy |
50-day SMA: | 19.16 | Buy |
200-day SMA: | 17.83 | Buy |
8-day EMA: | 18.89 | Buy |
20-day EMA: | 18.45 | Buy |
50-day EMA: | 18.66 | Buy |
200-day EMA: | 17.62 | Buy |
MANH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 208.37 | Buy |
20-day SMA: | 223.63 | Sell |
50-day SMA: | 239.96 | Sell |
200-day SMA: | 217.28 | Sell |
8-day EMA: | 211.81 | Sell |
20-day EMA: | 221.25 | Sell |
50-day EMA: | 231.14 | Sell |
200-day EMA: | 216.88 | Sell |
Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.49 per share.
Manhattan Associates Earnings Growth & MANH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.51 per share.
Kiniksa Pharmaceuticals Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Manhattan Associates Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |